AclinicaltrialofcombineduseofPienTzeHuangandTACE.docVIP

A clinical trial of combined use of Pien Tze Huang and TACE in the treatment of primary liver cancer Shui-lian ZHAO Jie PIAN Zhangzhou Pien Tze Huang Pharmaceutical Co.Ltd.Zhangzhou Fujian 363000,China *E-mail:pzhzsl@126.com Abstract:Objectives: We aimed to investigate the therapeutic effect of combined usage of Pien Tze Huang (PTH) on the treatment of primary liver cancer. Method: This Phase II randomized, double-blind, placebo-controlled clinical trial enrolled 240 patients with primary liver cancer. Patients were randomized to receive either TACE and PTH or TACE and placebo. PTH group was